Clinical trial Recruiting at 1 site Observational Ages 18 and up

Risk factors for mesh infection after abdominal wall reconstruction

Official title: Risk Factors for Mesh-Related Infection in Abdominal Wall Reconstruction: A Single-Centre Prospective Observational Cohort Study

Run by Minia University · NCT07725718 · Data updated 2026-11-12

This study tests which factors put adults at risk for mesh infection after abdominal wall reconstruction using different mesh types.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment420 (estimated)
SponsorMinia University
Academic / other
Locations1 site (Minya, Minya Governorate)
StatusRecruiting
StartedAugust 15, 2026
Main results expectedNovember 15, 2027
Study endsAugust 15, 2028
Registry record updatedAugust 18, 2026
Trial IDNCT07725718 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older undergoing elective or urgent abdominal wall reconstruction with synthetic, biosynthetic, or biological mesh for ventral, incisional, parastomal, or complex defects.

Probably not a fit

Patients without major risk factors or those receiving standard care may have no specific benefit beyond existing knowledge.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center observational cohort study at Minia University in Egypt. Consecutive adults undergoing abdominal wall reconstruction with mesh will be enrolled and followed for 12 months to identify independent risk factors for mesh-related infection within 90 days. Outcomes include infection timing, microbiology, need for mesh salvage or removal, and the occurrence of surgical site events, with an exploratory risk-stratification model to aid future risk prediction. No experimental interventions are applied; management follows standard unit practice. Enrollment spans 12 months, with complete follow-up for each participant lasting 12 months after surgery.</row>

Why it matters

Potential benefit: If successful, the study could help doctors identify patients at higher risk for mesh infection and tailor perioperative care to reduce infection rates.

How similar studies have gone: Previous research has shown variability in mesh infection risk factors, but prospective data with standardized definitions remain limited, making this study relatively novel in its setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged ≥18 years.
* Undergoing elective or urgent abdominal wall reconstruction with implantation of synthetic, biosynthetic or biological mesh for a ventral, incisional, parastomal or complex abdominal wall defect.
* Able and willing to provide written informed consent and to attend scheduled follow-up.

Exclusion Criteria:

* Suture-only repair without mesh.
* Inguinal or femoral (groin) hernia repair.
* Active systemic sepsis or established intra-abdominal mesh infection at the time of index surgery.
* Mesh placed solely for a non-reconstructive indication (e.g. temporary abdominal closure or planned re-look without definitive reconstruction).
* Estimated life expectancy \< 12 months or inability to complete the minimum follow-up.
* Patient declines participation.

Where it's running

  • Minia University Hospitals - Department of Surgery, Faculty of Medicine, Minia University
    Minya, Minya Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.